三生国健药业（上海）股份有限公司关于2024年限制性股票激励计划首次授予部分第一个归属期归属结果公告

Core Viewpoint - The announcement details the first vesting results of the 2024 restricted stock incentive plan by Sangfor Technologies, indicating that 1,300,710 shares have been vested to 76 individuals, with a six-month lock-up period before they can be traded [2][10]. Group 1: Stock Vesting Details - The number of restricted shares vested is 1,300,710 shares [2]. - The lock-up period for the vested shares is six months from the completion of the vesting registration [2]. - The vesting decision process involved multiple board meetings and approvals, including a public announcement of the incentive plan and its participants [3][4][5]. Group 2: Shareholder and Management Restrictions - Directors and senior management are subject to specific transfer restrictions, including a limit of 25% of their total shares per year during their tenure and a six-month restriction post-departure [7]. - Any trading of shares within six months of purchase or sale must result in profits being returned to the company [7][8]. Group 3: Financial Impact - Following the vesting, the total share capital of the company increased from 616,785,793 shares to 618,086,503 shares [10]. - The vested shares represent approximately 0.2109% of the company's total shares prior to vesting, which is not expected to have a significant impact on the company's financial condition or operating results [12]. - The basic earnings per share for the first nine months of 2025 will be diluted due to the increase in total shares, assuming net profit remains unchanged [11].